Three gas-liquid chromatographic (G.L.C.) procedures discussed have been designed around the four "esses" of detection tests -speed, sensitivity, simplicity, and specificity. These techniques are admirably applicable to the very low plasma drug levels encountered in blood testing under pre-race conditions. The methods are equally applicable to post-race testing procedures, where both blood and urine samples are tested.
INTRODUCTION
Although the methods to be discussed in this paper will be referred to the broader concepts of post-race testing, they were developed principally for rapid blood analyses under pre-race testing conditions. Presently, in the Commonwealth of Kentucky, there is no pre-race drug testing. However, both blood and urine are secured from each horse to be tested.
The analytical laboratory is called upon to detect drugs whose therapeutic blood levels may range from a few picograms per millilitre to about a milligram per milliitre -a variation of one-billionfold* in concentration levels. Obviously, the method adequate for reserpine detection might not be the method of choice for dipyrone or salicylic acid. Also, it would be highly desirable and forensically sound to develop "screening" methods for the parent drug as administered, as opposed to biotransformation or metabolic products.
The great majority of drugs sought by the equine *In USA billion -thousand million, i.e. 109 drug analyst lie in a concentration range of one nanogram per millilitre to one hundred micrograms per millilitre in blood or urine, with some notable exceptions. It is to find drugs in this concentration that most modern detection techniques are admirably suited.
Our -laboratory employs a "modular" detection scheme for analyses of prohibited drugs. Samples, both blood and urine, are processed in screw-cap culture tubes, 125 mm or 150 mm in length. Biological sample volumes vary from 3 ml to 17 ml. In these tubes, depending upon the procedure(s), samples are hydrolyzed, liquid-liquid extractions are performed, derivatizations are accomplished and final wash steps, if necessary, are completed. Detection procedures employ derivatizations for both thin layer and gas-liquid chromatography; thin layer chromatography, gas-liquid chromatography, and ultra-violet spectrophotometry. Using this "modular" testing concept, the laboratory at the University of Kentucky has, in the first seven months of operation, confirmed one prohibited drug per 145 samples tested. Of the prohibited drugs found, 50% were detected by one or more of the gas-chromatographic procedures to be discussed in this paper.
130
A technique which we use in our laboratory, and. which has been widely adopted for pre-race blood analyses employs gas-liquid chromatography (G.L.C.) with the electron capture detector (E.C.D.). As a gas chromatograph ic detector, the electron capture detector is very sensitive, perhaps 1,000 times more so than the commonly used flame ionization detector, The electron capture detector also detects only one-fifth as many substances as the flame ionization detector, and hence is a more specific detector.
The loss of standing current in the electron capture detector is a measure of the amount and electron affinity of the components in the carrier gas. This detector is extremely sensitive to certain molecules, such as organic and inorganic halogen-containing compounds. mentation followed by acylation, with promazine as the drug model. Three derivatization techniques will be discussed:
(1) direct derivatization of drugs containing primary or secondary amine or phenolic or alcoholic groups form strongly electron capturing amide and ester derivatives.
(2) reductive fragmentation followed by derivatization can be accomplished for some drugs which have groups which may be reduced with lithium aluminium hydride to form alcohols.
(3) oxidative fragmentation followed by derivatization is valuable for drugs which can be oxidized to form derivatizable groups.
In Tables I and II Acylation of methylphenidate by (a) direct derivatization with HFBA and (b) reductive fragmentation followed by direct derivatization with PFPA (Huffman and Blake, 1974 Acylation of promazine by oxidative fragmentation with KMnO4 followed by direct derivatization with HFBA (Blake and Tobin, 1976 To explain the three procedures the "rule(s)" of "three and four" will be used.
Direct derivatization or acylation of a drug involves the extraction of 3 ml of plasma mixed with 3 ml of saturated sodium tetraborate into 3 ml of cyclohexane. To the cyclohexane phase is added 50 microlitres of heptafluorobutyric or pentafluoropropionic anhydrides (HFBA or PFPA) and 50 microlitres of a pyridine/ benzene catalyst. Derivatization reaction time is 4 minutes, after which the cyclohexane phase is washed with 4 ml of 0.5N sodium hydroxide or 8 ml of saturated tetraborate solution. The derivatized drug(s) in the cyclohexane phase are now ready for G.L.C. analysis.
Reductive fragmentation followed by direct derivatization employs the extraction of 3 ml of plasma mixed with 3 ml of saturated sodium tetraborate into 3 ml of cyclohexane. To the cyclohexane phase is added 100 microlites of a saturated lithium aluminum hydride etherate to be followed by a 3-minute reduction reaction time. Twenty microlitres of distilled water is then added to the cyclohexane to stop reduction and destroy the excess LiAIH4. From this point on, the procedure is identical to the direct derivatization cited. Pentafluoropropionic anhydride with a tetraborate wash is used where alcoholic sites are to be derivatized.
Oxidative fragmentation followed by direct derivatization involves the extraction of 8 ml of whole blood into 3 ml of dichloromethane. Prior to extraction, 3 ml of a 1N ammonium hydroxide solution saturated with potassium permanganate is added to the whole blood, well mixed, allowing for an oxidation period of 4 minutes. Following extraction the procedure follows that of direct derivatization, except that after a sodium hydroxide wash, the dichloromethane must be carefully evaporated to dryness, and the residue picked up in benzene prior to chromatography.
Gas-liquid chromatographic conditions employ short, three or four feet, glass columns packed with a non-polar phase such as 3% OV-1, 3% OV-101, or 3% SE-30. In the laboratory, the Varian machines with scandium-tritide foils have proved to be excellent units for routine analyses, although other chromatographs would suffice.
In summary, the detection of drugs in the biological fluids of racehorses has taken a new trend because of the development and availability in the last 10 years of excellent sensitive, analytical instrumentation. General derivatizing procedures for drugs have provided specific and sensitive gas chromatographic tests. Procedures have been and will further evolve toward smaller sample volumes using simpler, more specific, more instrumented and probably more automated techniques.
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